Brand_Name_or_Equal_Justification_-_Amicus.pdf
PDF 117 KB Posted
- Attached to
- Leukocyte Reagents Federal contract opportunity
- Solicitation number
- N0025918Q0093
View the file
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
(Rev 8-19-10)
JUSTIFICATION AND APPROVAL - SIMPLIFIED ACQUISITIONS
Purchase Request No: N6847019RCBL008
Department: USNH Okinawa
POC/Tel. No.: MS. YOGI, Tomoko; 315-646-9957
Proposed Vendor:
FENWAL, A FRESENIUS KABI COMPANY
IAW FAR 13.106(1)(b)
1. Description of the supplies and/or services required to meet the end-user’s minimum needs :
The Armed Services Blood Bank Center, USNH Okinawa requires drop shipment of AMICUS Cell Separator System consumables and for blood processing reagents. The requested items are as follows: Sodium Chloride solution 12%; Sepacell
Leukocyte filter; Amicus Apheresis kit; and Intersol Solution.
2. Estimated value of the requirement:
Base year dollar value is $60,726.32. Two (2) additional option years are requested for this drop shipment contract.
3. Contractor’s unique qualifications which make him/her the ONLY source that can truly satisfy the Government’s minimum requirements:
Contractor must be able to provide reagents and supply that work with the current government-owned AMICUS Separator system. Amicus is the Original Equipment Manufacturer (OEM) of the reagent and consumable supply, the use of an unauthorized source for AMICUS Separator system may cause malfunction or damage to the system. Furthermore, the FDA licensure for platelets limits the collection to the methods, consumables, and system used during the collection of data for the license application.
4. Demonstration of the market search conducted appropriate to the size and complexity of the Government’s minimum requirements.
Include sources (in Government and industry) contacted and information obtained per source which further supports a sole source acquisition request.:
Market research was conducted through Cardinal Health, E-CAT and GSA Advantage. None of the requested items were available.
5. Other facts supporting the use of other than full and open competition:
None
6. Statement of the actions that are being taken to remove or overcome any barriers to competition:
USNH Okinawa is willing to accept other distributors if available.
File details come from the government source that posted it.